Glenmark Pharma said that it has got the US health regulator USFDA’s final approval for oral contraceptives and leukemia treatment injection.

It said in a BSE filing that “Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for drospirenone and ethinyl estradiol… and for levonorgestrel tablets.”

Read EquityPandit’s Technical Analysis on Nifty Pharma